Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.

NCT07437404 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Haemophilia A

Interventions

DRUG: SCT800 prophylaxis and treatment for bleeding events

Sponsor

Sinocelltech Ltd.